Frontiers and emerging trends in research on metabolic syndrome and metabolic dysfunction-associated fatty liver disease: a bibliometric analysis (2005-2024) - Top-Institutions - MDSpire

Frontiers and emerging trends in research on metabolic syndrome and metabolic dysfunction-associated fatty liver disease: a bibliometric analysis (2005-2024)

  • By

  • Weisong Zhang

  • Guangchen Liu

  • Xue Qu

  • Delong Cong

  • Yangyang Liu

  • May 22, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    University of California System
    University of California System

    Los Angeles, California

    Key Differentiators

    • Hepatology

  • #2

    National University Hospital, Singapore
    National University Hospital, Singapore

    Singapore, Singapore

    Key Differentiators

    • Hepatology

  • #3

    Leiden University
    Leiden University

    Leiden, Netherlands

    Key Differentiators

    • Hepatology

Original Source(s)

Frontiers and emerging trends in research on metabolic syndrome and metabolic dysfunction-associated fatty liver disease: a bibliometric analysis (2005-2024)

  • by Weisong Zhang, Guangchen Liu, Xue Qu, Delong Cong, Yangyang Liu

  • May 22, 2026

Related Content

Safety Framework for Gastric Mucosal Ablation (GMA) Using Hybrid Argon Plasma Coagulation (hAPC): International Expert Consensus

Hidden Gut Factor in Liver Disease

Healthy microbiome linked to reduced liver injury from Vibrio infection

  • May 8, 2026

  • 3 min
Addressing Tamoxifen-Associated Weight Gain: Lifestyle and Pharmacotherapy Options

Tamoxifen is commonly prescribed in hormone receptor-positive breast cancer but also associated with weight gain, which can complicate survivorship care. This narrative review summarizes evidence on tamoxifen-associated weight gain and outlines pharmacologic weight management options in this population.